The biotechnology firm IMMUNEONCO-B (01541) has announced a share repurchase activity.
On June 12, 2026, the company allocated HKD 8,722 to repurchase 2,600 of its own shares from the market.
The transaction was executed at a price range between HKD 3.35 and HKD 3.36 per share.